Skip to content

External therapy for Internal hemorrhoids in Siddha system of medicine

External therapy for Internal Hemorrhoids (Moolam) with Eruvai Mulai Thailam Poochu (Painting) and Cassia Ariculata tender leaves application (Poultice)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022465
Enrollment
30
Registered
2019-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

Intervention1: Eruvai Mulai Thailam: External application 1 ml of oil is applied through anal canal externally for 60 days Control Intervention1: Nil: Nil

Sponsors

AyothidossPandithar Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Grade I - III hemorrhoids with complaints / History of bleeding per rectum episodes intermittently. Patients signing the Informed consent form

Exclusion criteria

Exclusion criteria: Patients with History of Periproctitis or Hemorrhagic diathesis. Patients with features of Severe Hepatic or cardiovascular disorders. Patient with any type of Severe Infectious Disease. Patients who have been involved with another experimental drug trial within past 30 days. Patient presently diagnosed with Cancer. Patients who have known alcohol and drug abuse. Patients with abnormal values in blood and urine tests will be excluded

Design outcomes

Primary

MeasureTime frame
Patients with self reported assessment stating cured or improved compared with before treatment status and the objective assessment by investigator finding complete shrinking of pile mass and clearence of associated symptoms at the completion of treatment and 6 month post treatment.Modrate outcome: Partial reduction of pile mass and partiol relif of symptoms and/or reccurence within 6 months after cessation of treatment.Poor/Nil: No clearence of pile mass or no reduction of associated symptoms.Timepoint: 1 year

Secondary

MeasureTime frame
Patients with self reported assessment stating cured or improved compared with before treatment status and the objective assessment by investigator finding complete shrinking of pile mass and clearence of associated symptoms at the completion of treatment and 6 month post treatment.Modrate outcome: Partial reduction of pile mass and partiol relif of symptoms and/or reccurence within 6 months after cessation of treatment.Poor/Nil: No clearence of pile mass or no reduction of associated symptoms.Timepoint: 1 year

Countries

India

Contacts

Public ContactDr G J Christian

NATIONAL INSTITUTE OF SIDDHA

christianvijila@gmail.com9962545930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026